Toxic epidermal necrolysis after celecoxib therapy

Pharmacotherapy

Volumn 22, Issue 9, 2002, Pages 1193-1195

  Berger, Peter ^a   Dwyer, Daniel ^a   Corallo, Carmela E ^a  

^a BOX HILL HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; PROSTAGLANDIN SYNTHASE INHIBITOR; PYRAZOLE DERIVATIVE; SULFONAMIDE; ALLOPURINOL; ANTICONVULSIVE AGENT; CHLORHEXIDINE; ENOXAPARIN; ETACRYNIC ACID; HUMAN IMMUNOGLOBULIN; HYDROCORTISONE; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; PARAFFIN; PREDNISOLONE;

AGED; ARTICLE; CASE REPORT; FEMALE; HUMAN; OSTEOARTHRITIS; PATHOLOGY; SKIN; TOXIC EPIDERMAL NECROLYSIS; CLINICAL FEATURE; DRUG INDUCED DISEASE; ECZEMA; HUMAN TISSUE; INTENSIVE CARE; SKIN BIOPSY;

AGED; AGED, 80 AND OVER; CYCLOOXYGENASE INHIBITORS; EPIDERMAL NECROLYSIS, TOXIC; FEMALE; HUMANS; OSTEOARTHRITIS; PYRAZOLES; SKIN; SULFONAMIDES; CASE REPORT; HUMAN;

EID: 0036708223     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.22.13.1193.33513     Document Type: Article

References (10)

1. Drug-induced toxic epidermal necrolysis
2. Adverse drug reactions and the dermatologist
3. Severe adverse cutaneous reactions to drugs
4. A case of epidermal necrolysis treated with intravenous immunoglobulin
5. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis
6. Allergic skin reaction to celecoxib
7. Celecoxib: Early Australian reporting experience
8. A large population-based follow-up study of trimethoprim-sulfamethoxazole, trimethoprim, and cephalexin for uncommon serious drug toxicity
9. Immunologic tolerability profile of celecoxib
10. Celecoxib